organism: Homo sapiens
description: Pt_B_D-32
attributes.tag: Common Name
attributes.value: Human
attributes.tag: Sample Name
attributes.value: Pt_B_D-32
attributes.tag: Scientific Name
attributes.value: Homo sapiens
attributes.tag: Subject
attributes.value: Pt_B
attributes.tag: Submission description
attributes.value: We are uploading data from our targeted panel used in the publication referenced here, at the reuqest of the reviewers from Nature Medicine. The variant data included is from patients treated with IDH2 inhibitor Enasidanib who exhibited primary or acquired resistance to the investigational agent.
attributes.tag: Submission identifier
attributes.value: GSB-151
attributes.tag: Submission title
attributes.value: Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations